The Top 5 Biosimilar Articles for the Week of June 27

July 01, 2022

Here are the top 5 biosimilar articles for the week of June 27, 2022.

Biosimilars Business Roundup: June 2022
Henlius Begins Phase 3 Trials for Denosumab Biosimilar
Consulting With Clinical Pharmacists May Help Boost Biosimilar Adoption
Contributor: No Animal Testing of Biosimilars—US Congress Begins Amendment to BPCIA